Yeon Soo Baik

Yeon Soo Baik, PhD is an Assistant Scientist in the Department of International Health at Johns Hopkins Bloomberg School of Public Health, specializing in epidemiology with a focus on tuberculosis and HIV research. Their work spans multiple international settings including Uganda, South Africa, Botswana, and Bangladesh, addressing critical questions in infectious disease control and public health implementation.

Dr. Baik completed their PhD at the University of California Los Angeles in 2019, with subsequent postdoctoral training in epidemiology. Their research expertise encompasses epidemiologic methods, translational epidemiology, molecular epidemiology, transmission and prediction modeling, longitudinal cohort analysis, and health economics specifically applied to TB/HIV research.

Dr. Baik's research program demonstrates strong focus on implementation science, with numerous projects examining tuberculosis self-testing strategies in Peru, diagnostic accuracy of GeneXpert Ultra testing in South Africa, validation of clinical risk scores for early TB management in Uganda, and evaluation of short-course tuberculosis preventive therapy delivery options. They have also investigated Korea's contribution to global tuberculosis eradication efforts.

Analysis of their recent publications reveals consistent focus on tuberculosis prevention and treatment among people living with HIV, with particular attention to implementation barriers, cost considerations, and patient preferences in resource-limited settings. Their work increasingly incorporates methodological approaches from health economics and behavioral science to address implementation challenges.

Dr. Baik actively collaborates with researchers across multiple institutions and countries, with research output showing steady growth from 2018 to 2025. Their work has been cited in various contexts, including news outlets and social media, indicating broader impact beyond academic circles.

Through their research, Dr. Baik has established expertise in quantitative epidemiology that extends beyond TB/HIV to include Chagas disease, respiratory and neurological diseases, and sexually transmitted infections, demonstrating methodological versatility in addressing diverse public health challenges.